METHODIST DALLAS MEDICAL CENTER
1. Target Overview & Investment Thesis
METHODIST DALLAS MEDICAL CENTER is a 375-bed suburban community hospital in DALLAS, TX with $555.7M in net patient revenue and a -5.4% operating margin. The hospital serves a payer mix of 14.2% Medicare, 4.3% Medicaid, and 81.5% commercial.
Thesis: Undervalued. Our ML models identify $40.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -5.4% to 2.0% (+736bps).
| Net Revenue HCRIS | $555.7M |
| Current EBITDA COMPUTED | $-30.0M |
| Operating Margin COMPUTED | -5.4% |
| Occupancy HCRIS | 66.6% |
| Revenue / Bed COMPUTED | $1.5M |
| Net-to-Gross HCRIS | 25.2% |
| Distress Probability ML | 43.8% |
2. Market Context & Competitive Position
TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of -5.4% places it below the state median. Among 104 size-comparable peers (188-750 beds), the median margin is 4.3%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (188-750), prioritizing same-state peers. 104 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| METHODIST DALLAS MEDICAL CENTE (Target) | TX | 375 | $555.7M | -5.4% |
| UT MD ANDERSON CANCER CENTER | TX | 721 | $4.90B | -0.8% |
| UT SOUTHWESTERN UNIVERSITY HOS | TX | 737 | $2.28B | -4.6% |
| SCOTT AND WHITE MEMORIAL HOSPI | TX | 616 | $1.85B | -10.5% |
| CHILDRENS MEDICAL CENTER OF DA | TX | 377 | $1.56B | 10.3% |
| COOK CHILDRENS MEDICAL CENTER | TX | 423 | $1.51B | 16.5% |
| CHI ST LUKES HEALTH BAYLOR MED | TX | 628 | $1.10B | -9.5% |
| UNIVERSITY HEALTH SYSTEM | TX | 657 | $1.10B | -50.0% |
| TX HLTH HARRIS METHODIST HOSPI | TX | 653 | $1.03B | 4.1% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $40.9M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $11.7M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $11.1M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $11.0M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $6.8M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $356K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-30.0M |
| + RCM Uplift | +$40.9M |
| Pro Forma EBITDA | $10.9M |
| Current Margin | -5.4% |
| Pro Forma Margin | 2.0% |
| WC Released (1x) | $21.3M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-46.1M | $211.4M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-46.1M | $217.6M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-41.5M | $337.6M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-41.5M | $356.0M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-50.7M | $21.9M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-50.7M | $7.6M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 104 hospitals with 188-750 beds
- Same-state prioritization (n=105)
- Comp margins: P25=-8.5% / P50=4.3% / P75=14.6%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.